• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项旨在改善肥胖儿科患者合理用药剂量的质量改进计划。

A Quality Initiative to Improve Appropriate Medication Dosing in Pediatric Patients with Obesity.

作者信息

Cloyd Colleen P, Macedone Danielle, Merandi Jenna, Pierson Shawn, Sellas Wcislo Maria, Lutmer Jeffrey, MacDonald Jennifer, Ayad Onsy, Kalata Lindsay, Thompson R Zachary

机构信息

From the Department of Pharmacy, Nationwide Children's Hospital, Columbus Ohio.

Department of Critical Care Medicine, Nationwide Children's Hospital, Columbus, Ohio.

出版信息

Pediatr Qual Saf. 2024 Jun 11;9(3):e741. doi: 10.1097/pq9.0000000000000741. eCollection 2024 May-Jun.

DOI:10.1097/pq9.0000000000000741
PMID:38868757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11167219/
Abstract

INTRODUCTION

Emerging evidence supports the use of alternative dosing weights for medications in patients with obesity. Pediatric obesity presents a particular challenge because most medications are dosed based on patient weight. Additionally, building system-wide pediatric obesity safeguards is difficult due to pediatric obesity definitions of body mass index-percentile-for-age via the Center for Disease Control growth charts. We describe a quality initiative to increase appropriate medication dosing in inpatients with obesity. The specific aim was to increase appropriate dosing for 7 high-risk medications in inpatients with obesity ≥2 years old from 37% to >74% and to sustain for 1 year.

METHODS

The Institute for Healthcare Improvement model for improvement was used to plan interventions and track outcomes progress. Interventions included a literature review to establish internal dosing guidance, electronic health record (EHR) functionality to identify pediatric patients with obesity, a default selection for medication weight with an opt-out, and obtaining patient heights in the emergency department.

RESULTS

Appropriate dosing weight use in medication ordered for patients with obesity increased from 37% to 83.4% and was sustained above the goal of 74% for 12 months.

CONCLUSIONS

Implementation of EHR-based clinical decision support has increased appropriate evidence-based dosing of medications in pediatric and adult inpatients with obesity. Future studies should investigate the clinical and safety implications of using alternative dosing weights in pediatric patients.

摘要

引言

新出现的证据支持肥胖患者使用替代给药体重来用药。儿童肥胖带来了特殊挑战,因为大多数药物是根据患者体重给药的。此外,由于疾病控制中心生长图表中儿童肥胖的年龄别体重指数百分位定义,建立全系统的儿童肥胖保障措施很困难。我们描述了一项旨在增加肥胖住院患者适当药物剂量的质量改进计划。具体目标是将≥2岁肥胖住院患者7种高风险药物的适当给药率从37%提高到>74%,并维持1年。

方法

采用医疗保健改进研究所的改进模型来规划干预措施并跟踪结果进展。干预措施包括进行文献综述以制定内部给药指南、电子健康记录(EHR)功能以识别肥胖儿科患者、默认选择药物体重并可选择退出,以及在急诊科获取患者身高。

结果

为肥胖患者开具的药物中适当给药体重的使用率从37%提高到83.4%,并在12个月内维持在74%以上的目标水平。

结论

基于EHR的临床决策支持的实施增加了肥胖儿科和成人住院患者药物基于证据的适当给药。未来的研究应调查在儿科患者中使用替代给药体重的临床和安全影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/7b9f7f4457f9/pqs-9-e741-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/36be6f10d0c5/pqs-9-e741-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/723b3e2c4134/pqs-9-e741-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/3a1573870968/pqs-9-e741-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/708ec2b7a35c/pqs-9-e741-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/7b9f7f4457f9/pqs-9-e741-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/36be6f10d0c5/pqs-9-e741-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/723b3e2c4134/pqs-9-e741-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/3a1573870968/pqs-9-e741-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/708ec2b7a35c/pqs-9-e741-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/404c/11167219/7b9f7f4457f9/pqs-9-e741-g005.jpg

相似文献

1
A Quality Initiative to Improve Appropriate Medication Dosing in Pediatric Patients with Obesity.一项旨在改善肥胖儿科患者合理用药剂量的质量改进计划。
Pediatr Qual Saf. 2024 Jun 11;9(3):e741. doi: 10.1097/pq9.0000000000000741. eCollection 2024 May-Jun.
2
Impact of guided weight-based medication dosing in pediatric patients with obesity.引导基于体重的药物剂量在肥胖儿童患者中的影响。
J Am Pharm Assoc (2003). 2023 May-Jun;63(3):873-877. doi: 10.1016/j.japh.2023.02.012. Epub 2023 Feb 12.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
5
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
6
7
Development of recommendations for dosing of commonly prescribed medications in critically ill obese children.制定危重症肥胖儿童常用处方药给药剂量的建议。
Am J Health Syst Pharm. 2015 Apr 1;72(7):542-56. doi: 10.2146/ajhp140280.
8
Transition to a new electronic health record and pediatric medication safety: lessons learned in pediatrics within a large academic health system.向新的电子健康记录和儿科药物安全过渡:大型学术医疗系统内儿科的经验教训。
J Am Med Inform Assoc. 2018 Jul 1;25(7):848-854. doi: 10.1093/jamia/ocy034.
9
Improving Hydroxychloroquine Dosing and Toxicity Screening at a Tertiary Care Ambulatory Center: A Quality Improvement Initiative.提高三级护理门诊羟氯喹的剂量和毒性筛查:一项质量改进计划。
J Rheumatol. 2021 Jan 1;48(1):138-144. doi: 10.3899/jrheum.191265. Epub 2020 Apr 1.
10
Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative.连续性肾脏替代治疗在危重症患者中的剂量:一项质量改进计划。
Am J Kidney Dis. 2019 Dec;74(6):727-735. doi: 10.1053/j.ajkd.2019.06.013. Epub 2019 Sep 17.

本文引用的文献

1
Executive Summary: Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity.执行摘要:儿童和青少年肥胖评估与治疗临床实践指南。
Pediatrics. 2023 Feb 1;151(2). doi: 10.1542/peds.2022-060641.
2
A Systematic Review of Nudge Interventions to Optimize Medication Prescribing.优化药物处方的助推干预措施的系统评价
Front Pharmacol. 2022 Jan 25;13:798916. doi: 10.3389/fphar.2022.798916. eCollection 2022.
3
Evaluation of Dexmedetomidine Dosing in Obese Critically Ill Patients.肥胖重症患者右美托咪定给药剂量的评估
J Pharm Pract. 2023 Feb;36(1):67-73. doi: 10.1177/08971900211021578. Epub 2021 Jun 10.
4
Unfractionated heparin using actual body weight without dose capping in obese pediatric patients-Subgroup analysis from an observational cohort study.肥胖儿科患者中不设定剂量上限、根据实际体重使用未分级肝素的研究:一项观察性队列研究的亚组分析。
Pediatr Blood Cancer. 2021 Mar;68(3):e28872. doi: 10.1002/pbc.28872. Epub 2021 Jan 5.
5
Pediatric Life Support 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.2020 年儿童生命支持国际心肺复苏和紧急心血管急救科学共识及治疗推荐。
Pediatrics. 2021 Jan;147(Suppl 1). doi: 10.1542/peds.2020-038505B. Epub 2020 Oct 21.
6
Impact of Obesity on Voriconazole Pharmacokinetics among Pediatric Hematopoietic Cell Transplant Recipients.肥胖对儿科造血干细胞移植受者伏立康唑药代动力学的影响。
Antimicrob Agents Chemother. 2020 Nov 17;64(12). doi: 10.1128/AAC.00653-20.
7
Drug dosing in the critically ill obese patient-a focus on sedation, analgesia, and delirium.危重症肥胖患者的药物剂量调整——关注镇静、镇痛和谵妄。
Crit Care. 2020 Jun 8;24(1):315. doi: 10.1186/s13054-020-03040-z.
8
The effectiveness of behavioral economics-informed interventions on physician behavioral change: A systematic literature review.行为经济学干预措施对医生行为改变的有效性:系统文献回顾。
PLoS One. 2020 Jun 4;15(6):e0234149. doi: 10.1371/journal.pone.0234149. eCollection 2020.
9
Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease.静脉注射免疫球蛋白导致川崎病肥胖患者溶血
Front Pediatr. 2020 Apr 3;8:146. doi: 10.3389/fped.2020.00146. eCollection 2020.
10
Vancomycin Dosing in Children With Overweight or Obesity: A Systematic Review and Meta-analysis.超重或肥胖儿童的万古霉素给药:系统评价与荟萃分析
Hosp Pediatr. 2020 Apr;10(4):359-368. doi: 10.1542/hpeds.2019-0287. Epub 2020 Mar 25.